At the end of the latest market close, Affimed N.V. (AFMD) was valued at $1.17. In that particular session, Stock kicked-off at the price of $1.15 while reaching the peak value of $1.20 and lowest value recorded on the day was $1.13. The stock current value is $1.18.Recently in News on January 9, 2023, Affimed Reports on Corporate Progress and Provides Regulatory Update for AFM13. AFM13 combination with Artiva’s AB-101 NK cells: Received written feedback to pre-investigational new drug (IND) meeting request which supports plan for IND filing in H1 2023 and initiation of clinical study during 2023. You can read further details here
Affimed N.V. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.3400 on 01/03/23, with the lowest value was $1.0400 for the same time period, recorded on 01/12/23.
Affimed N.V. (AFMD) full year performance was -72.27%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Affimed N.V. shares are logging -76.86% during the 52-week period from high price, and 14.56% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.03 and $5.10.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1295603 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Affimed N.V. (AFMD) recorded performance in the market was -5.65%, having the revenues showcasing -24.52% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 169.24M, as it employees total of 187 workers.
Analysts verdict on Affimed N.V. (AFMD)
During the last month, 0 analysts gave the Affimed N.V. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.8265, with a change in the price was noted -1.53. In a similar fashion, Affimed N.V. posted a movement of -56.46% for the period of last 100 days, recording 1,802,462 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AFMD is recording 0.10 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.07.
Affimed N.V. (AFMD): Technical Analysis
Raw Stochastic average of Affimed N.V. in the period of last 50 days is set at 9.87%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 46.67%. In the last 20 days, the company’s Stochastic %K was 45.56% and its Stochastic %D was recorded 42.22%.
Let’s take a glance in the erstwhile performances of Affimed N.V., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -5.65%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -62.14%, alongside a downfall of -72.27% for the period of the last 12 months. The shares increased approximately by 9.35% in the 7-day charts and went up by 4.46% in the period of the last 30 days. Common stock shares were lifted by -24.52% during last recorded quarter.